| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2022 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BLACK STONE MINERALS | 11 | Q3 2023 | 82.2% |
| Evelo Bioseciences Inc | 11 | Q3 2023 | 7.3% |
| BIOSIG TECH INC | 10 | Q2 2023 | 6.7% |
| Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC) | 10 | Q3 2023 | 3.5% |
| Zentalis Pharmaceuticals Inc | 9 | Q3 2023 | 22.6% |
| UNITY BIOTECHNOLOGY INC | 8 | Q4 2022 | 23.1% |
| EXACT SCIENCES CORP | 7 | Q2 2023 | 4.5% |
| Neuroon Medical Technologies | 5 | Q3 2023 | 1.3% |
| MSCI ACWI ETF | 4 | Q3 2023 | 89.6% |
| Sorrento Therapeutics | 4 | Q4 2022 | 6.1% |
View Mayo Clinic's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VENTURE LENDING & LEASING IV INC | March 16, 2005 | 6,000 | 6.0% |
View Mayo Clinic's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-05 |
| 13F-HR/A | 2023-02-09 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
View Mayo Clinic's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.